Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Akero Therapeutics, Inc. (AKRO)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 8-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Assets |
| Cash and equivalents | 444.2 | 257.9 | 249.8 | 177.7 | 150.5 | 150.5 | 164.9 | 157.5 |
| Short-term investments | 195.3 | 383.7 | 393.9 | 157.8 | 144.3 | 191.8 | 239.3 | 296.4 |
| Other current assets | 3.8 | -294.1 | -288.5 | -151.4 | -126.9 | -148.7 | -182.5 | -217.7 |
| Total current assets | 643.2 | 347.5 | 355.2 | 184.1 | 167.9 | 193.6 | 221.8 | 236.2 |
| Property, plant, and equipment, net | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Long-term investments | 19.5 | | | | | | | |
| Other fixed assets | | 0.1 | 0.1 | 0.1 | 0.5 | 0.4 | 0.1 | 0.1 |
| Total assets | 663.8 | 348.8 | 356.6 | 185.7 | 169.9 | 195.5 | 223.5 | 238.0 |
| |
| Accounts payable | 10.1 | 7.1 | 8.0 | 6.9 | 4.5 | 6.7 | 6.8 | 2.3 |
| Accrued expenses | 11.5 | 9.6 | 11.1 | 19.8 | 17.6 | 18.4 | 16.8 | 14.2 |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total current liabilities | 21.6 | 16.7 | 19.1 | 26.7 | 22.1 | 25.1 | 23.5 | 16.5 |
| Long-term debt | 24.7 | 24.6 | 9.5 | 9.4 | | | | |
| Other liabilities | 1.0 | 1.2 | 1.4 | 1.2 | 1.3 | 1.3 | 1.4 | 1.4 |
| Total liabilities | 47.4 | 42.5 | 30.0 | 37.3 | 23.4 | 26.4 | 24.9 | 17.9 |
| |
| Shareholders' equity [+] | 616.4 | 306.3 | 326.6 | 148.4 | 146.5 | 169.1 | 198.6 | 220.1 |
| Paid-in capital | 1,095.9 | 754.5 | 748.9 | 512.1 | 482.9 | 479.4 | 476.5 | 473.7 |
| Retained earnings | -479.3 | -448.2 | -422.3 | -363.7 | -336.3 | -310.3 | -277.9 | -253.6 |
| Tangible shareholders' equity | 616.4 | 306.3 | 326.6 | 148.4 | 146.5 | 169.1 | 198.6 | 220.1 |
|